Helping the Diabetes Community in Ukraine – 6/1 Update
Guide on how to support the diabetes community in Ukraine.
Celebrating the Best of 2021
In 2021, Breakthrough T1D has seen tremendous progress in accelerating cures, improving lives, and advocating for people with type 1…
Find Your Something
A resident physician and T1D dad—who also lives with an autoimmune disease—shares his call to action to support Breakthrough T1D…
On Medicare? Accessing CGMs Just Got Easier
A recent update to continuous glucose monitor (CGM) coverage requirements will make it easier for people covered by Medicare to…
FDA Advisory Committee Recommends that Teplizumab Receives Approval
An FDA Advisory Committee weighed the evidence, and the results were positive: They recommended that the FDA approve teplizumab for…
Breakthrough T1D Advocates Have Been Hard at Work
Through these meetings, advocates give a voice to those impacted by T1D.
The CDC Updates its Guidelines to Prioritize T1D
On March 29, 2021, the U.S. Centers for Disease Control and Prevention (CDC) updated its guidelines to include type 1…